Aliyah Patterson from Edmond fights to save her vision after being diagnosed with Keratoconus, a rare eye condition causing ...

Corneal crosslinking failure rates were low in a US registry analysis, but CXL failure risk was doubled for patients aged younger than 18 years.

The specialist physician made the remarks at a media briefing held at the National Eye Hospital auditorium in Colombo to mark ...

The National Eye Hospital has issued a warning about a growing number of cases of keratoconus, an eye disorder that causes distorted vision.

Keratoconus, a progressive eye disorder that distorts vision, is increasingly being detected among Sri Lankans, including ...

A progressive eye condition, Keratoconus, is increasingly affecting young adults due to digital lifestyles. This disorder ...

Keratoconus, a progressive eye disorder that distorts vision, is increasingly being detected among Sri Lankans, including ...

Glaukos Corporation (NYSE:GKOS) Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator ...

Epioxa is a small molecule drug delivered as an eye drop that strengthens the cornea.

Clinicians discuss how the treatment compares with epi-off cross-linking, what may shape adoption, and how patient outcomes could improve. Gloria B. Chiu, OD, FAAO, FSLS, associate professor of ...

Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator today. At this time, I would like to welcome you to the Glaukos Corporation's Third Quarter 2025 ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for ...